Probiotic Strain Reverses Age-Related Muscle Weakness in Preclinical Study

Age-related muscle loss (sarcopenia) affects nearly half of adults over 80 and significantly impairs quality of life. A new study in Scientific Reports reports that a specific probiotic strain, Bifidobacterium animalis subsp. lactis DS109-B11, ameliorated muscle weakness in aging models by activating AMPK—a master metabolic regulator linked to longevity. The researchers found that this probiotic improved grip strength, muscle mass, and mitochondrial function. The benefits appeared to work through the gut-muscle axis: the bacteria likely produce metabolites that activate AMPK signaling, which enhances energy metabolism and may reduce muscle protein breakdown. AMPK activation is the same pathway stimulated by metformin and exercise, both associated with healthy aging. The major caveat: this was an animal study, not human research. Probiotic effects are notoriously strain-specific and don't always translate across species. The gut microbiome's role in sarcopenia is an active research area, but we lack clinical trials showing any probiotic can meaningfully prevent or reverse human muscle loss. That said, the mechanistic findings are intriguing, and this specific strain could be worth testing in older adults—especially given probiotics' general safety profile.